| Type of support |
Approvals 2001-2021 (US$)(29 Jun 2017) |
Commitments 2001-2021 (US$)(29 Jun 2017) |
Disbursements 2000-2017 (US$)(29 Jun 2017) |
% Disbursed(29 Jun 2017) |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
|---|
|
| Total |
$50,514,359 |
$69,198,859 |
$45,476,466 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash Support (CASHSUPP) |
$188,000 |
$213,000 |
$188,000 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Civil Society Organisation support (CSO) |
|
|
$268,308 |
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cold Chain Equipment Optimisation Platform (CCEOP) |
$2,811,728 |
$2,811,728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Health system strengthening (HSS 1) |
$3,643,081 |
$4,916,581 |
$3,643,081 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HPV Demo (NVS) |
$357,276 |
$357,276 |
$357,779 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Immunisation services support (ISS) |
$2,990,600 |
$2,990,600 |
$2,990,600 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Injection Safety Devices (NVS) |
$106,000 |
$444,000 |
$95,400 |
90% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Injection safety support (INS) |
$317,617 |
$317,617 |
$317,617 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IPV (NVS) |
$30,504 |
$30,504 |
$25,364 |
83% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Meningitis A - campaign (NVS) |
$2,063,527 |
$2,063,527 |
$2,063,614 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Meningitis A - operational costs (OPC) |
$1,744,601 |
$1,744,601 |
$1,744,601 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Penta (NVS) |
$15,410,117 |
$18,177,117 |
$15,416,362 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pneumo (NVS) |
$12,777,671 |
$22,366,671 |
$10,717,691 |
84% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rotavirus (NVS) |
$4,509,683 |
$8,255,683 |
$3,923,657 |
87% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vaccine Introduction Grant (VIG) |
$845,066 |
$845,066 |
$845,066 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Yellow Fever (NVS) |
$2,718,888 |
$3,664,888 |
$2,879,326 |
106% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding
Download data for commitments, approvals & disbursements in XLS format